Ultragenyx Pharmaceutical (RARE) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Jul 15, as the stock is now trading above the volatile price range of $39.89 to $43.27.
In the last 30 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Ultragenyx Pharmaceutical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Actelion Ltd. (ALIOF), Illumina Inc. (ILMN) and Curis, Inc. (CRIS). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ULTRAGENYX PHARMACEUTICAL INC (RARE): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
CURIS INC (CRIS): Free Stock Analysis Report
ILLUMINA INC (ILMN): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading